INEX and Alnylam Announce Allowance of New U.S. Patent Covering Delivery of RNAi Therapeutics
New Patent Broadly Covers Delivery of RNAi Therapeutics with Cationic Liposomes
09-Mar-2007 -
Inex Pharmaceuticals Corporation and Alnylam Pharmaceuticals, Inc. announced that the United States Patent and Trademark Office (USPTO) has allowed claims in a patent application that covers nucleic acid-lipid compositions, including cationic liposomes, a family of specialized lipid molecules. ...
acids
Alnylam
oligonucleotides
+1